{
    "clinical_study": {
        "@rank": "82307", 
        "brief_summary": {
            "textblock": "This purpose of this study is to determine the ability of an\n      18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET scan to detect a focal lesion of\n      hyperinsulinism and determine the location in patients with congenital hyperinsulinism,\n      Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected."
        }, 
        "brief_title": "18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia", 
        "condition": [
            "Congenital Hyperinsulinism", 
            "Beckwith-Wiedemann Syndrome", 
            "Insulinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Beckwith-Wiedemann Syndrome", 
                "Hyperinsulinism", 
                "Hypoglycemia", 
                "Insulinoma", 
                "Persistent Hyperinsulinemia Hypoglycemia of Infancy", 
                "Nesidioblastosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects of any age with hyperinsulinemic hypoglycemia, diagnosed by a fasting test\n             and/or response to glucagon stimulation.\n\n          -  Subjects who are eligible for pancreatic surgery regardless of prior pancreatic\n             surgery\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating females\n\n          -  Any other major illness or condition that in the investigator's judgment will\n             substantially increase the risk associated with the subject's participation in this\n             study\n\n          -  Subjects who are not a candidate for pancreatic surgery"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "July 30, 2013", 
        "id_info": {
            "nct_id": "NCT01916148", 
            "org_study_id": "12-009528"
        }, 
        "intervention": {
            "description": "18F-DOPA is a PET scan radiotracer.", 
            "intervention_name": "18F-DOPA", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Dihydroxyphenylalanine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Hypoglycemia", 
            "Hyperinsulinism"
        ], 
        "lastchanged_date": "February 5, 2014", 
        "official_title": "Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia", 
        "overall_contact": {
            "email": "Beckers@email.chop.edu", 
            "last_name": "Susan Becker, RN, BSN, CCRC", 
            "phone": "267-426-0269"
        }, 
        "overall_contact_backup": {
            "email": "States@email.chop.edu", 
            "last_name": "Lisa States, MD", 
            "phone": "267-425-7146"
        }, 
        "overall_status": "Available", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01916148"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Children's Hospital of Philadelphia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Hospital of Philadelphia", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "February 2014"
    }
}